Monitoring of Epstein-Barr virus DNA load in peripheral blood by quantitative competitive PCR

Journal of Clinical Microbiology

Volumn 37, Issue 9, 1999, Pages 2852-2857

  Stevens, Servi J C ^a   Vervoort, Marcel B H J ^a   Van Den Brule, Adriaan J C ^a   Meenhorst, Pieter L ^b   Meijer, Chris J L M ^a   Middeldorp, Jaap M ^a,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c Organon Teknika   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID DNA; VIRUS DNA;

ACCURACY; ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; DNA DETERMINATION; ENZYME IMMUNOASSAY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LUMINESCENCE; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REPRODUCIBILITY; VALIDATION PROCESS;

EID: 0032773098     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.9.2852-2857.1999     Document Type: Article

References (25)

1. Adams, A. 1987. Replication of latent Epstein-Barr virus genomes in Raji cells. J. Virol. 61:1743-1746.
2. Bai, X., G. Hosler, B. B. Rogers, D. B. Dawson, and R. H. Scheuermann. 1997. Quantitative polymerase chain reaction for human herpesvirus diagnosis and measurement of Epstein-Barr virus burden in posttransplant lymphoproliferative disorder. Clin. Chem. 43:1843-1849.
3. Bhatia, K., A. Raj, M. I. Guitierrez, J. G. Judde, G. Spangler, H. Venkatesh, and I. T. Magrath. 1996. Variation in the sequence of Epstein-Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene 13:177-181.
4. Boom, R., C. J. A. Sol, M. M. M. Salimans, C. L. Jansen, P. M. E. Wertheimvan Dillen, and J. Van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
5. Drouet, E., P. Brousset, F. Fares, J. Icart, C. Verniol, F. Meggetto, D. Schlaifer, H. Desmorat-Coat, F. Rigal-Higuet, A. Niveleau, and G. Delsol. 1999. High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's disease. J. Med. Virol. 57:383-389.
6. International Agency for Research on Cancer. 1997. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 70. Epstein-Barr virus and Kaposi sarcoma herpesvirus/human herpesvirus 8. International Agency for Research on Cancer, Lyon, France.
7. Jacobs, M. V., A. J. C. van den Brule, P. J. F. Snijders, T. Helmerhorst, C. J. L. M. Meijer, and J. M. M. Walboomers. 1996. A non-radioactive PCR enzyme-immunoassay enables a rapid identification of HPV 16 and 18 in cervical smears after GP5+/6-f PCR. J. Med. Virol. 49:223-229.
8. Jiwa, N. M., P. Kanavaros, P. C. de Bruin, P. van der Valk, A. Horstman, W. Vos, H. Mullink, J. M. Walboomers, and C. J. L. M. Meijer. 1993. Presence of Epstein-Barr virus harbouring small and intermediate sized cells in Hodgkin's disease. Is there a relationship with Reed-Sternberg cells? J. Pathol. 170:129-136.
9. Kenagy, D. N., Y. Schlesinger, K. Weck, J. H. Ritter, M. M. Gaudreault-Keener, and G. A. Storch. 1995. Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation 60:547-554.
10. Kersten, M. J., M. R. Klein, A. M. Holwerda, F. Miedema, and M. H. van Oers. 1997. Epstein-Barr virus specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma. J. Clin. Investig. 99:1525-1533.
11. Kieff, E. 1996. Epstein-Barr virus and its replication, p. 2343-2396. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology. Lippincott-Raven Publishers, Philadelphia, Pa.
12. Kwok, S., and R. Higuchi. 1989. Avoiding false positives with PCR. Nature 339:237-238.
13. Laroche, C., E. B. Drouet, P. Brousset, C. Pain, A. Boibieux, F. Biron, J. Icart, G. A. Denoyel, and A. Niveleau. 1995. Measurement by the polymerase chain reaction of the Epstein-Barr virus load in infectious mononucleosis and AIDS-related non-Hodgkin's lymphomas. J. Med. Virol. 46:56-74.
14. Lawrence, J. B., C. A. Villnave, and R. H. Singer. 1988. Sensitive high resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line. Cell 51:51-61.
15. Lucas, K. G., R. L. Burton, S. E. Zimmerman, J. Wang, K. G. Cornetta, K. A. Robertson, C. H. Lee, and D. J. Emanuel. 1998. Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood 91:3654-3661.
16. Mouritsen, L., C. T. Wittwer, G. Reed, T. M. Khan, T. B. Martins, T. D. Jaskowski, C. M. Litwin, and H. R. Hill. 1997. Detection of Epstein-Barr viral DNA in serum using rapid-cycle PCR. Biochem. Mol. Med. 60:161-168.
17. Mutirangura, A., W. Pornthanakasem, A. Theamboonlers, V. Sriuranpong, P. Lertsanguansinchi, S. Yenrudi, N. Voravud, P. Supiyaphun, and Y. Poovorawan. 1998. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clin. Cancer Res. 4:665-669.
18. Riddler, S. A., M. C. Breinig, and J. L. C. McKnight. 1994. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 84:972-984.
19. Rooney, C. M., S. K. Loftin, M. S. Holladay, M. K. Brenner, and R. A. Krance. 1995. Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br. J. Haematol. 89:98-103.
20. Rowe, D. T., L. Lu, J. Reyes, N. Jabbour, E. Yunis, P. Putnam, S. Todo, and M. Green. 1997. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric patients and risk of lymphoproliferative disorders. J. Clin. Microbiol. 35:1612-1615.
21. Snudden, D. K., P. R. Smith, D. Lai, M. Ng, and B. E. Griffin. 1995. Alterations in the structure of the EBV nuclear antigen, EBNA-1, in epithelial tumours. Oncogene 10:1545-1552.
22. Van den Brule, A. J. C., C. J. L. M. Meijer, V. Bakels, P. Kenemans, and J. M. M. Walboomers. 1990. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J. Clin. Microbiol. 28:2739-2743.
23. Wagner, H. J., G. Bein, A. Bitsch, and H. Kirchner. 1992. Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-sero-positive, healthy individuals by polymerase chain reaction. J. Clin. Microbiol. 30:2826-2829.
24. Wrightham, M. N., J. P. Stewart, N. J. Janjua, S. D. Pepper, C. Sample, C. M. Rooney, and J. R. Arrand. 1995. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology 208:521-530.
25. Zimmermann, K., and J. W. Mannhalter. 1996. Technical aspects of quantitative competitive PCR. BioTechniques 21:268-279.